annual CFO:
-$87.87M+$506.87M(+85.23%)Summary
- As of today (June 28, 2025), APLS annual cash flow from operations is -$87.87 million, with the most recent change of +$506.87 million (+85.23%) on December 31, 2024.
- During the last 3 years, APLS annual CFO has risen by +$475.26 million (+84.40%).
- APLS annual CFO is now -2450.76% below its all-time high of -$3.44 million, reached on December 31, 2013.
Performance
APLS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$53.41M-$72.77M(-375.88%)Summary
- As of today (June 28, 2025), APLS quarterly cash flow from operations is -$53.41 million, with the most recent change of -$72.77 million (-375.88%) on March 31, 2025.
- Over the past year, APLS quarterly CFO has increased by +$79.57 million (+59.84%).
- APLS quarterly CFO is now -137.62% below its all-time high of $141.98 million, reached on December 31, 2020.
Performance
APLS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$8.29M+$79.57M(+90.56%)Summary
- As of today (June 28, 2025), APLS TTM cash flow from operations is -$8.29 million, with the most recent change of +$79.57 million (+90.56%) on March 31, 2025.
- Over the past year, APLS TTM CFO has increased by +$541.80 million (+98.49%).
- APLS TTM CFO is now at all-time high.
Performance
APLS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
APLS Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +85.2% | +59.8% | +98.5% |
3 y3 years | +84.4% | +52.1% | +98.4% |
5 y5 years | +58.4% | +50.7% | +97.1% |
APLS Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +85.2% | -256.6% | +69.9% | at high | +98.7% |
5 y | 5-year | at high | +85.2% | -137.6% | +69.9% | at high | +98.7% |
alltime | all time | -2450.8% | +85.2% | -137.6% | +69.9% | at high | +98.7% |
APLS Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$53.41M(-375.9%) | -$8.29M(-90.6%) |
Dec 2024 | -$87.87M(-85.2%) | $19.36M(-43.2%) | -$87.87M(-57.2%) |
Sep 2024 | - | $34.10M(-508.9%) | -$205.10M(-49.8%) |
Jun 2024 | - | -$8.34M(-93.7%) | -$408.28M(-25.8%) |
Mar 2024 | - | -$132.98M(+35.9%) | -$550.10M(-7.5%) |
Dec 2023 | -$594.74M(+15.8%) | -$97.88M(-42.1%) | -$594.74M(-6.7%) |
Sep 2023 | - | -$169.09M(+12.6%) | -$637.60M(+2.4%) |
Jun 2023 | - | -$150.16M(-15.5%) | -$622.94M(+7.4%) |
Mar 2023 | - | -$177.62M(+26.2%) | -$579.80M(+12.9%) |
Dec 2022 | -$513.75M(-8.8%) | -$140.74M(-8.9%) | -$513.75M(+5.8%) |
Sep 2022 | - | -$154.42M(+44.3%) | -$485.50M(-2.8%) |
Jun 2022 | - | -$107.02M(-4.1%) | -$499.71M(-4.2%) |
Mar 2022 | - | -$111.56M(-0.8%) | -$521.37M(-7.4%) |
Dec 2021 | -$563.13M(+250.9%) | -$112.50M(-33.3%) | -$563.13M(+82.4%) |
Sep 2021 | - | -$168.63M(+31.0%) | -$308.65M(+28.7%) |
Jun 2021 | - | -$128.69M(-16.1%) | -$239.85M(+16.7%) |
Mar 2021 | - | -$153.31M(-208.0%) | -$205.45M(+28.0%) |
Dec 2020 | -$160.49M | $141.98M(-242.2%) | -$160.49M(-58.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$99.82M(+5.9%) | -$384.54M(+13.7%) |
Jun 2020 | - | -$94.29M(-13.0%) | -$338.31M(+19.2%) |
Mar 2020 | - | -$108.35M(+32.0%) | -$283.92M(+34.5%) |
Dec 2019 | -$211.13M(+60.9%) | -$82.07M(+53.1%) | -$211.13M(+21.7%) |
Sep 2019 | - | -$53.60M(+34.3%) | -$173.54M(+13.4%) |
Jun 2019 | - | -$39.91M(+12.2%) | -$153.08M(+6.4%) |
Mar 2019 | - | -$35.56M(-20.1%) | -$143.87M(+9.6%) |
Dec 2018 | -$131.24M(+181.7%) | -$44.48M(+34.2%) | -$131.24M(+28.3%) |
Sep 2018 | - | -$33.13M(+7.9%) | -$102.30M(+27.4%) |
Jun 2018 | - | -$30.69M(+33.8%) | -$80.30M(+31.4%) |
Mar 2018 | - | -$22.94M(+47.7%) | -$61.10M(+31.1%) |
Dec 2017 | -$46.60M(+79.2%) | -$15.53M(+39.5%) | -$46.60M(+50.0%) |
Sep 2017 | - | -$11.14M(-3.1%) | -$31.06M(+55.9%) |
Jun 2017 | - | -$11.50M(+36.4%) | -$19.92M(+136.4%) |
Mar 2017 | - | -$8.43M | -$8.43M |
Dec 2016 | -$26.00M(+37.9%) | - | - |
Dec 2015 | -$18.86M(+89.6%) | - | - |
Dec 2014 | -$9.95M(+188.8%) | - | - |
Dec 2013 | -$3.44M | - | - |
FAQ
- What is Apellis Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual CFO year-on-year change?
- What is Apellis Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly CFO year-on-year change?
- What is Apellis Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM CFO year-on-year change?
What is Apellis Pharmaceuticals annual cash flow from operations?
The current annual CFO of APLS is -$87.87M
What is the all time high annual CFO for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual cash flow from operations is -$3.44M
What is Apellis Pharmaceuticals annual CFO year-on-year change?
Over the past year, APLS annual cash flow from operations has changed by +$506.87M (+85.23%)
What is Apellis Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of APLS is -$53.41M
What is the all time high quarterly CFO for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly cash flow from operations is $141.98M
What is Apellis Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, APLS quarterly cash flow from operations has changed by +$79.57M (+59.84%)
What is Apellis Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of APLS is -$8.29M
What is the all time high TTM CFO for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM cash flow from operations is -$8.29M
What is Apellis Pharmaceuticals TTM CFO year-on-year change?
Over the past year, APLS TTM cash flow from operations has changed by +$541.80M (+98.49%)